COEP Coeptis Therapeutics, Inc.: שווי נכסים נקי

The price history on the COEP chart on the GURU.Markets platform is currently at 0.02. Coeptis Therapeutics brings together leading specialists to develop cell therapies, providing them with cutting-edge equipment and budgets. The business relies on multi-channel air freight and vetted couriers to eliminate supply chain disruptions. High profitability is maintained through the use of specialized cooling systems during the transportation of biomaterials.

For Coeptis Therapeutics (COEP), which lacks revenue and depends on external investments for the development of cell therapies, this metric serves as the sole measure of financial viability in the face of FDA regulatory risks. By analyzing the book value of equity, an investor assesses the difference between all assets and liabilities, which determines the actual volume of equity protecting the company from bankruptcy and confirming its long-term solvency.